| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:P2X7-IN-2
CAS:1058709-63-9
Package:1removed
|
Benzeneacetamide, N-[2-[(1R)-2-amino-1-methylethyl]-1,2-dihydro-6-methyl-1-oxo-5-isoquinolinyl]-3-fluoro-4-(trifluoromethyl)- manufacturers
- P2X7-IN-2
-
- $1520.00 / 25mg
-
2026-05-11
- CAS:1058709-63-9
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Benzeneacetamide, N-[2-[(1R)-2-amino-1-methylethyl]-1,2-dihydro-6-methyl-1-oxo-5-isoquinolinyl]-3-fluoro-4-(trifluoromethyl)- Basic information |
| | Benzeneacetamide, N-[2-[(1R)-2-amino-1-methylethyl]-1,2-dihydro-6-methyl-1-oxo-5-isoquinolinyl]-3-fluoro-4-(trifluoromethyl)- Chemical Properties |
| Boiling point | 607.4±55.0 °C(Predicted) | | density | 1.357±0.06 g/cm3(Predicted) | | pka | 13.27±0.20(Predicted) |
| | Benzeneacetamide, N-[2-[(1R)-2-amino-1-methylethyl]-1,2-dihydro-6-methyl-1-oxo-5-isoquinolinyl]-3-fluoro-4-(trifluoromethyl)- Usage And Synthesis |
| Uses | P2X7-IN-2 (compound 58) is a P2X7 receptor inhibitor. P2X7-IN-2 inhibits IL-Iβ release with an IC50 value of 0.01 nM. P2X7-IN-2 can be used for the research of autoimmunity, inflammation and cardiovascular disease[1]. | | References | [1] Kelly, Michael G, et al. Preparation of isoquinolonecarboxamides as P2X7 purinoceptor modulators and uses thereof. WO2008112205 A1. 2008. |
| | Benzeneacetamide, N-[2-[(1R)-2-amino-1-methylethyl]-1,2-dihydro-6-methyl-1-oxo-5-isoquinolinyl]-3-fluoro-4-(trifluoromethyl)- Preparation Products And Raw materials |
|